About us
About us
Futura Medical is the developer of innovative sexual health products, including lead product Eroxon^®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Explore this section
Who we are
Our business model
Our strategy
Board of directors
Eroxon^®
Eroxon^®
Our lead product is Eroxon^®a clinically proven breakthrough treatment for erectile dysfunction
What is Eroxon^®
Eroxon^® at a glance
Clinical data
Marketplace
Commercial partners
Commercialisation
Eroxon^® FAQs
PIPELINE
PIPELINE
Futura has two new products in its development pipeline, Eroxon^® Intense and WSD4000 for the treatment of sexual dysfunction in men and women.
Eroxon^® Intense
WSD4000 - For the treatment of sexual dysfunction in women
Investor centre
Investor centre
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
WEBCASTS
Explore this section
Share price chart
Corporate documentation
Videos and webcasts
Videos and webcasts
Videos
Webcasts
RNS
Alert service
Shareholder centre
Shareholder centre
Investor contacts and advisors
Shareholder information
Financial calendar
Investor FAQs
Analyst Research
Corporate Governance
AIM rule 26
Media
Media
This section contains the latest RNS, news and videos.
Explore this section
News
Event calendar
RNS
Videos
Alert service
Contact us

About us
Eroxon^®
PIPELINE
- Eroxon^® Intense
- WSD4000 - For the treatment of sexual dysfunction in women
Investor centre
Media
Contact us

Share price chart

Interactive chart

* Shares in issue number updated periodically. Please check regulatory announcements for the most up to date position.

Designed and developed by
jonesandpalmer.co.uk